Epibiotech Co., Ltd. (XKON:446440)
14,880
+380 (2.62%)
At close: Jan 28, 2026
7.28% (1Y)
| Market Cap | 32.30B -9.3% |
| Revenue (ttm) | 449.62M +15.9% |
| Net Income | -5.06B |
| EPS | -2,966.00 |
| Shares Out | 2.31M |
| PE Ratio | n/a |
| Forward PE | n/a |
| Dividend | n/a |
| Ex-Dividend Date | n/a |
| Volume | 406 |
| Average Volume | 112 |
| Open | 14,980 |
| Previous Close | 14,500 |
| Day's Range | 12,340 - 14,980 |
| 52-Week Range | 9,600 - 19,000 |
| Beta | 1.24 |
| RSI | 37.53 |
| Earnings Date | n/a |